Proactive Investors - Run By Investors For Investors

Valens GroWorks raises C$43M to expand geographic presence and increase production capacity

The company will use the funds to expand its domestic geographic presence, increase production capacity and white label offerings
extraction vial
Valens has extraction processing and supply agreements with a number of leading producers across Canada

Valens GroWorks Corporation (CSE:VGW) (OTCMKTS:VGWCF) announced Tuesday it had closed a C$43 million bought-deal financing.

The Kelowna-based cannabis company said it will use the funds to strategically increase its domestic geographic presence, increase production capacity and white label offerings and for general corporate purposes.

READ: Valens GroWorks increasing equity financing deal with 37.5 million dollars

The offering was led by AltaCorp Capital Inc, which as sole bookrunner and lead underwriter, along with a syndicate of underwriters, purchased more than 14.6 million units at C$2.95 a pop to raise C$43.1 million.

Other underwriters include GMP Securities, Raymond James, Haywood Securities and Mackie Research Capital.

Valens shares dipped to C$3.14 on Tuesday in Toronto and to US$2.35 in New York.

Contact Katie Lewis at [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full VGW profile View Profile

Valens GroWorks Corporation Timeline

Related Articles

FSD Pharma facility
June 11 2019
The indoor hydroponic facility will be optimized for large-scale, medical-grade cannabis production and once complete, is expected to have over 3.9 million sq/ft available for production
cannabis plant
December 14 2018
The Vancouver-based cannabis group services medical and recreational cannabis markets in Canada and internationally
cannabis leaf next to bottle
April 29 2019
The cannabis holding company has four unique, synergistic business under its umbrella
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use